Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening

Journal of Urology

Volumn 193, Issue 1, 2015, Pages 75-79

  Liss, Michael A ^a   Chen, Haitao ^b,c   Hemal, Sij ^c   Krane, Spencer ^c   Kane, Christopher J ^a   Xu, Jianfeng ^b,c   Kader, A Karim ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^b FUDAN UNIVERSITY   (China)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

European continental ancestry group; mass screening; mortality; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; CAUCASIAN; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BLOOD; EARLY DIAGNOSIS; ETHNOLOGY; GENETICS; MIDDLE AGED; MORTALITY; PROSTATE TUMOR;

AGED; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 85028173173     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.07.085     Document Type: Article

References (16)

1. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2013. CA Cancer J Clin, 63, 2013, 11.
2. Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360, 2009, 1310.
3. Schroder, F.H., Hugosson, J., Roobol, M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med, 360, 2009, 1320.
4. Pinsky, P.F., Blacka, A., Kramer, B.S., et al. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials, 7, 2010, 303.
5. Moyer, V.A., Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force. Ann Intern Med, 157, 2012, 120.
6. Carter, H.B., Albertsen, P.C., Barry, M.J., et al. Early detection of prostate cancer: AUA guideline. J Urol, 190, 2013, 419.
7. Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst, 104, 2012, 125.
8. Andriole, G.L., Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Recent results. Cancer Res, 202, 2014, 53.
9. Elshafei, A., Moussa, A.S., Hatem, A., et al. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?. Urology, 81, 2013, 826.
10. Thompson, I.M., Ankerst, D.P., Chi, C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst, 98, 2006, 529.
11. Hugosson, J., Carlsson, S., Aus, G., et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol, 11, 2010, 725.
12. Roudgari, H., Hemminki, K., Brandt, A., et al. Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database. J Med Genet, 49, 2012, 345.
13. Ziogas, A., Anton-Culver, H., Validation of family history data in cancer family registries. Am J Prev Med, 24, 2002, 190.
14. Murff, H.J., Spigel, D.R., Syngal, S., Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA, 292, 2004, 1480.
15. Zheng, S.L., Sun, J., Wiklund, F., et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med, 358, 2008, 910.
16. Sun, J., Na, R., Hsu, F.C., et al. Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history. Eur Urol, 63, 2013, 585.